MetLife Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
33,150
-395
| -1% | -$41.9K | 0.02% | 733 |
|
|
2025
Q1 | $4.16M | Sell |
33,545
-531
| -2% | -$65.9K | 0.02% | 709 |
|
|
2024
Q4 | $4.2M | Buy |
34,076
+2,162
| +7% | +$266K | 0.02% | 663 |
|
|
2024
Q3 | $3.56M | Sell |
31,914
-1,242
| -4% | -$138K | 0.02% | 722 |
|
|
2024
Q2 | $3.54M | Sell |
33,156
-2,700
| -8% | -$288K | 0.02% | 682 |
|
|
2024
Q1 | $4.32M | Sell |
35,856
-908
| -2% | -$109K | 0.03% | 572 |
|
|
2023
Q4 | $4.52M | Sell |
36,764
-692
| -2% | -$85.1K | 0.03% | 515 |
|
|
2023
Q3 | $4.85M | Sell |
37,456
-2,159
| -5% | -$279K | 0.04% | 417 |
|
|
2023
Q2 | $4.91M | Buy |
39,615
+1,032
| +3% | +$128K | 0.04% | 451 |
|
|
2023
Q1 | $5.65M | Sell |
38,583
-1,033
| -3% | -$151K | 0.04% | 382 |
|
|
2022
Q4 | $6.31M | Sell |
39,616
-603
| -1% | -$96.1K | 0.05% | 329 |
|
|
2022
Q3 | $5.36M | Sell |
40,219
-280
| -0.7% | -$37.3K | 0.04% | 375 |
|
|
2022
Q2 | $6.32M | Buy |
40,499
+775
| +2% | +$121K | 0.05% | 313 |
|
|
2022
Q1 | $6.18M | Buy |
39,724
+9,935
| +33% | +$1.55M | 0.04% | 397 |
|
|
2021
Q4 | $3.8M | Buy |
29,789
+412
| +1% | +$52.5K | 0.03% | 541 |
|
|
2021
Q3 | $3.83M | Sell |
29,377
-652
| -2% | -$84.9K | 0.03% | 505 |
|
|
2021
Q2 | $5.33M | Buy |
30,029
+935
| +3% | +$166K | 0.05% | 360 |
|
|
2021
Q1 | $4.78M | Sell |
29,094
-1,394
| -5% | -$229K | 0.04% | 411 |
|
|
2020
Q4 | $5.03M | Sell |
30,488
-1,265
| -4% | -$209K | 0.05% | 356 |
|
|
2020
Q3 | $4.53M | Buy |
+31,753
| New | +$4.53M | 0.05% | 346 |
|
|
2019
Q2 | – | Sell |
-81
| Closed | -$11.6K | – | 2518 |
|
|
2019
Q1 | $11.6K | Buy |
81
+1
| +1% | +$143 | ﹤0.01% | 2383 |
|
|
2018
Q4 | $9.92K | Sell |
80
-1
| -1% | -$124 | ﹤0.01% | 2378 |
|
|
2018
Q3 | $13.6K | Buy |
+81
| New | +$13.6K | ﹤0.01% | 2408 |
|